Koninklijke Philips (NYSE:PHG – Get Free Report) has been assigned an average rating of “Hold” from the five brokerages that are currently covering the firm, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a hold recommendation and one has issued a buy recommendation on the company.
PHG has been the subject of a number of analyst reports. Jefferies Financial Group raised Koninklijke Philips from an “underperform” rating to a “hold” rating in a report on Tuesday, October 29th. StockNews.com downgraded shares of Koninklijke Philips from a “buy” rating to a “hold” rating in a report on Thursday, November 14th.
View Our Latest Research Report on Koninklijke Philips
Koninklijke Philips Price Performance
Hedge Funds Weigh In On Koninklijke Philips
Institutional investors and hedge funds have recently bought and sold shares of the business. Wilmington Savings Fund Society FSB bought a new position in shares of Koninklijke Philips in the third quarter valued at about $54,000. Fairscale Capital LLC acquired a new stake in Koninklijke Philips in the 2nd quarter valued at about $54,000. Eastern Bank bought a new position in shares of Koninklijke Philips in the third quarter worth about $88,000. RPg Family Wealth Advisory LLC acquired a new position in shares of Koninklijke Philips during the third quarter worth approximately $107,000. Finally, Blue Trust Inc. grew its stake in shares of Koninklijke Philips by 902.7% during the second quarter. Blue Trust Inc. now owns 3,700 shares of the technology company’s stock valued at $93,000 after purchasing an additional 3,331 shares during the last quarter. Institutional investors and hedge funds own 13.67% of the company’s stock.
About Koninklijke Philips
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
See Also
- Five stocks we like better than Koninklijke Philips
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- 5 Reasons DraftKings Stock Looks Promising in the New Year
- How to Use the MarketBeat Stock Screener
- Cybersecurity Stocks: 1 Immediate Buy and 1 Dip Opportunity
- Airline Stocks – Top Airline Stocks to Buy Now
- The Next 2 AI Winners Have Triple-Digit Upside Potential
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.